EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human leukocyte extract enhances albendazole efficacy against Echinococcus multilocularis in mice by reducing parasitic microRNAs, myeloid and lymphoid immunosuppressive cells

Gabriela Hrčková iD, Emília Dvorožňáková, Dagmar Mudroňová, Zuzana Jurčacková, Terézia Mačak Kubašková, Miroslava Petrová, Annamaria Bardelčíková

PLOS Neglected Tropical Diseases · 14.08.2026 · 20 (8) · e0014591

DOI: 10.1371/journal.pntd.0014591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 14.08.2026. Verfasst von Gabriela Hrčková und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Parasitology, Slovak Academy of Sciences, Košice, Slovakia. Hauptthemen laut MEDLINE: Albendazole, Echinococcus multilocularis, MicroRNAs, Echinococcosis. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agentúra na Podporu Výskumu a Vývoja, Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Echinococcus multilocularis induces a serious zoonotic infection in humans and growth of metacestodes is associated with immunosuppression and tolerance. Current treatment relies almost exclusively on albendazole, a parasitostatic drug with variable clinical efficacy. Human low molecular weight leukocyte extract (HLE) has been shown to modulate innate and adaptive immunity at various diseases and can serve as promising and safe adjuvant to chemotherapy. Methodology In the present study we investigated the effects of albendazole (ABZ), human leukocyte extract (HLE) and their combination on murine alveolar echinococcosis, developing in the peritoneal cavities, by monitoring cysts weight, levels of circulating parasitic miRNAs, cytokine levels by ELISA and qPCR, the proportions of lymphoid and myeloid cells in spleens and peritoneal cavities by flow cytometry and proliferation of T and B lymphocytes and NO production ex vivo. Principal findings Albendazole therapy moderately reduced cyst mass, selectively altered circulating parasite-derived miRNA levels in line with moderate decrease of IL-10 and TGF-β and myeloid-derived suppressor cells without the effects on suppressed T and B cells proliferation and high NO production. HLE in combination with ABZ significantly reduced peritoneal cyst growth and these two therapies markedly decreased circulating parasite derived microRNAs and expression of T- and B-regulatory cells lineage-specific transcription factors. These molecular changes were accompanied by a marked restoration of T and B lymphocyte proliferation, significant decline of regulatory IL-10 and TGF-β cytokines and immunosuppressive myeloid cells and MHC II low (M2) macrophages in spleens and peritoneal cavities, where HLE and ABZ + HLE interventions suppressed NO production and altered cytokine expression. The effect probably involved NF-κB downregulation, preventing excessive inflammation while enhancing ABZ efficacy.

Conclusions

HLE as adjuvant enhanced albendazole efficacy against Echinococcus multilocularis infection in mice via reduction of T regulatoty type of response and MDSC expansion and shift of systemic and local immunity toward balanced Th1/Th2- biased profiles. The marked reduction in circulating parasite-derived miRNAs identifies a previously unrecognised mechanism that may contribute to the immunomodulatory effects of HLE and highlights these molecules as potential biomarkers of therapeutic response. Collectively, these results propose HLE as a promising adjunct immunotherapeutic candidate capable of counteracting parasite-induced immunosuppression and potentiating benzimidazole chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbendazoleEchinococcus multilocularisMicroRNAsEchinococcosisAnthelminticsTransfer FactorAnimalsMiceHumansFemaleCytokinesMyeloid CellsLymphocytesDisease Models, Animal

Substanzen

AlbendazoleMicroRNAsAnthelminticsCytokinesTransfer Factor

Autor:innen und Institutionen

  • Institute of Parasitology, Slovak Academy of Sciences, Košice, Slovakia.
  • Department of Microbiology and Immunology, University of Veterinary Medicine and Pharmacy, Košice, Slovakia.
  • Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafarik University, Košice, Slovakia.

ORCID-Profile: Gabriela Hrčková

Förderung

  • Agentúra na Podporu Výskumu a Vývoja
  • Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR

Zitieren

APA

Hrčková, G., Dvorožňáková, E., Mudroňová, D., Jurčacková, Z., Mačak Kubašková, T., Petrová, M., & Bardelčíková, A. (2026). Human leukocyte extract enhances albendazole efficacy against Echinococcus multilocularis in mice by reducing parasitic microRNAs, myeloid and lymphoid immunosuppressive cells. PLOS Neglected Tropical Diseases, 20(8), e0014591. https://doi.org/10.1371/journal.pntd.0014591

Vancouver

Hrčková G, Dvorožňáková E, Mudroňová D, Jurčacková Z, Mačak Kubašková T, Petrová M, et al. Human leukocyte extract enhances albendazole efficacy against Echinococcus multilocularis in mice by reducing parasitic microRNAs, myeloid and lymphoid immunosuppressive cells. PLOS Neglected Tropical Diseases. 2026;20(8):e0014591. doi:10.1371/journal.pntd.0014591

BibTeX
@article{Hrkov2026,
  author = {Hrčková, Gabriela and Dvorožňáková, Emília and Mudroňová, Dagmar and Jurčacková, Zuzana and Mačak Kubašková, Terézia and Petrová, Miroslava and Bardelčíková, Annamaria},
  title = {Human leukocyte extract enhances albendazole efficacy against Echinococcus multilocularis in mice by reducing parasitic microRNAs, myeloid and lymphoid immunosuppressive cells},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  volume = {20},
  number = {8},
  pages = {e0014591},
  doi = {10.1371/journal.pntd.0014591}
}
Kostenlos starten →